House OKs drug safety bill

The House of Representatives passed a bill on Wednesday that backs new FDA authority over drug safety, including allowing the FDA to require new studies, order label changes and monitor drugs on the market. The bill also renews for five years two programs to collect user fees from drug and medical device manufacturers.

View Full Article in:

Google · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD